3Feinberg WM, Blackshear JL, Laupacis A, et al. Prevalence, age distribution, and gender of patients with atrial fibrillation [ J]. Arch Intern Med, 1995, 155:469.
4Garrigus S, Barold SS, Cazeau S, et al. Prevention of atrial arrhythmias during DDD pacing by atrial overdrive [J]. PACE, 1998,21 :1751.
5Kale M, Bennett DH. Pacemaker prevention therapies for the control of drug-refractory paroxysmal atrial fibrillation [ J ]. Europace,2003, 5:123.
6Dijkman B, Wellens HJ. Diagnosis and therapy of atrial tachyarrhythmias in the dual chamber implantable cardioverter defibrillator[J]. J Cardiovasc Electrophysiol, 2000, 11:1196.
7Israel CW, Hugl B, Unterberg C, et al. Pace-termination and pacing for prevention of atrial tachyarrhythmias : Results from a multicenter study with an implantable device for atrial therapy Cardiovasc Electrophysiol, 2001,12 : 1121.
8Ricci R, Santini M, Padeletti L, et al. Atrial tachyarrhythmia recurrence temporal patterns in bradycardia patients implanted with antitachycardia pacemakers [ J]. J Cardiovasc Electrophysiol, 2004,15:44.
9Vollmann D, Stevens J, Buchwald AB, et al. Automatic atrial antitachy pacing for the termination of spontaneous atrial tachyarrhythmias: Clinical experience with a novel dual-chamber pacemaker[J]. J Interv Card Electrophysiol, 2001, 5:477.
10Stephenson EA, Casavant D, Tuzi J, et al. Efficacy of atrial anti-tachycardia pacing using the Medtronic AT500 pacemaker in patients with congenital heart disease [ J]. Am J Cardiol, 2003, 92:871.
